Trademark Overview
On Monday, March 31, 2025, a trademark application was filed for CDAC with the United States Patent and Trademark Office. The USPTO has given the CDAC trademark a serial number of 99111946. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 31, 2025. This trademark is owned by BeiGene Switzerland GmbH. The CDAC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical products development relevant to Chimeric Degradation Activation Compounds; Scientific and technological research relating to Chimeric Degradation Activation Compounds; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; platform as a service (PAAS) featuring computer software platforms for scientific research information in the field of pharmaceuticals and clinical trials